Featured Research

from universities, journals, and other organizations

Tapeworm's Chemical Trick Could Make Drugs More Effective

Date:
March 4, 2003
Source:
University Of Wisconsin-Madison
Summary:
To survive and thrive in a decidedly hostile environment, the lowly tapeworm uses a chemical trick to evade the propulsive nature of its intestinal home.

MADISON - To survive and thrive in a decidedly hostile environment, the lowly tapeworm uses a chemical trick to evade the propulsive nature of its intestinal home.

Capitalizing on that tapeworm chemistry, scientists at the University of Wisconsin-Madison believe they may have found a way to slow the transit of drugs through the intestine, making them more effective in their delivery and holding out the promise not only of more effective treatment, but also of lowering dosage and cost, and eliminating wasted medicine.

This new insight comes via the tapeworm Hymenolepis diminuta, a species found in rats and long used as a research model by parasitologists. By sorting through the soup of biochemicals the tapeworm uses to influence muscle activity in the gut, a group led by John Oaks of the School of Veterinary Medicine, and Paul Bass of the School of Pharmacy has isolated a chemical signal factor that may help prolong the time it takes for medicines to move through the small intestine.

"Most oral medications would benefit from prolonged small intestinal residence," says Bass, an emeritus professor of pharmacy. "Almost all drugs we take orally are absorbed from the small intestine. By prolonging the medication's residence time in that organ, we should enhance its absorption and obtain higher blood levels of the medication."

The compound characterized by Oaks and Bass, known in scientific shorthand as cyclic GMP, is a member of a family of compounds known generically as signal factors. Its role is to alter the electrochemical activity of the muscles in the intestine, slowing or shutting down intestinal transit of the host, actions that help the tapeworm obtain a meal or otherwise survive in an organ designed to quickly sweep food along.

"Inside cells, cyclic GMP is a signal molecule," notes Oaks, a professor of comparative bioscience. "It tells cells how to behave. When the tapeworm secretes this signal molecule, the intestine closes off and nothing moves. That suggested to us that the intestine is not digesting material as it normally would."

The cyclic GMP compound, Oaks adds, is cheap and easy to synthesize. Its use as an additive to medicines has been patented by the Wisconsin Alumni Research Foundation.

"Many drugs are absorbed at less than 50 percent from the intestine," says Oaks. "The key will be can we use cyclic GMP with certain kinds of drugs to increase their level of uptake into the blood?"

An example of a drug that might be more effective if it passed through the intestine at a slower pace is Fosamax, a medicine used to combat osteoporosis that is made by the pharmaceutical giant Merck. The company claimed Fosamax sales totaling $1.3 billion in 2000.

"It currently is taken by many women to prevent or treat osteoporosis," Bass says. "But this medication is only 1 percent absorbed. We believe our signal factor could possibly enhance absorption and thereby reduce the amount of medication that is taken."

By lowering dosages of different medications, it might be possible to lower the cost of medicines. Some drugs are prohibitively expensive to produce and reducing dosages could help consumers now contending with the escalating costs of many pharmaceuticals.

Other potential benefits associated with lower dosages include lessened side effects and fewer chemicals released into the environment. A recent survey of surface water in the United States revealed a growing presence of drugs in the environment. The suspected sources are medicines that are not completely metabolized by the humans and animals they are administered to.

"If we could halve the dosage, we could lower the percentage of nonabsorbed drug that ends up in the environment," says Oaks.

The work done by the Wisconsin team, which also included K. Dubear Kroening and Noah P. Zimmerman, was funded in part by a grant from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Wisconsin-Madison. Note: Materials may be edited for content and length.


Cite This Page:

University Of Wisconsin-Madison. "Tapeworm's Chemical Trick Could Make Drugs More Effective." ScienceDaily. ScienceDaily, 4 March 2003. <www.sciencedaily.com/releases/2003/03/030304073334.htm>.
University Of Wisconsin-Madison. (2003, March 4). Tapeworm's Chemical Trick Could Make Drugs More Effective. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2003/03/030304073334.htm
University Of Wisconsin-Madison. "Tapeworm's Chemical Trick Could Make Drugs More Effective." ScienceDaily. www.sciencedaily.com/releases/2003/03/030304073334.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins